NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial
NCT01303640
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
3235
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
Biolimus-eluting stent
DEVICE:
Everolimus-eluting stent
Sponsor
Takeshi Morimoto